Thursday, 29 November 2018

FDA Approves New Drug For Leukemia

AML is a rapidly progressing cancer that crowds out normal cells in the bone marrow and bloodstream, resulting in low numbers of normal blood cells and a continuous need for transfusions, reports...

from NDTV News - Latest https://ift.tt/2DSipdT
via

No comments:

Post a Comment

Lower Entry Barriers After Record Antitrust Fine: Alibaba As Shares Rally

Alibaba Group CEO Daniel Zhang said on Monday he does not expect any material impact from the change of exclusivity arrangement imposed by C...